
Since 1948, when zzso et zzso introduced zzso the first zzso agent, more than 100 such agents have come into zzso Initially, zzso zzso were thought to produce only zzso or zzso effects on dividing tumor cells as it was often associated with the damage to healthy zzso and the development of resistant tumor zzso However, that view has been changing as a consequence of recent demonstrations that several zzso drugs, even at low doses, have zzso and sometimes zzso zzso In addition, new studies indicate that lowering the dose of conventional zzso agents and combining chemotherapy with other zzso may not only decrease the toxicity of conventional chemotherapy, but also zzso the efficacy of different zzso zzso Giving chemotherapy in this manner has several potential advantages, including impediment of the onset of zzso mechanisms of acquired drug resistance and increase in the efficacy and durability of zzso therapeutic zzso Certain zzso forms of cancer chemotherapy may cause indirect zzso of immune cells due to the accessibility of tumor zzso and certain zzso zzso Furthermore, new findings indicate that several zzso agents can directly activate immune cells when used in ultra low zzso zzso the new phenomenon that was termed zzso The goal of this review is to analyze the immune modulating properties of zzso zzso agents and present new evidence of the zzso zzso of several agents used in low and ultra low nontoxic zzso zzso zzso of combined zzso regimens have been extensively reviewed in a variety of recent publications and will not be zzso 

